These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1965141)

  • 1. Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease.
    Cohen A; Madrid-Marina V; Estrov Z; Freedman MH; Lingwood CA; Dosch HM
    Int Immunol; 1990; 2(1):1-8. PubMed ID: 1965141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor.
    Cohen A; Hannigan GE; Williams BR; Lingwood CA
    J Biol Chem; 1987 Dec; 262(35):17088-91. PubMed ID: 2824515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.
    LaCasse EC; Bray MR; Patterson B; Lim WM; Perampalam S; Radvanyi LG; Keating A; Stewart AK; Buckstein R; Sandhu JS; Miller N; Banerjee D; Singh D; Belch AR; Pilarski LM; Gariépy J
    Blood; 1999 Oct; 94(8):2901-10. PubMed ID: 10515895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digalactosyl-containing glycolipids as cell surface receptors for shiga toxin of Shigella dysenteriae 1 and related cytotoxins of Escherichia coli.
    Brown JE; Echeverria P; Lindberg AA
    Rev Infect Dis; 1991; 13 Suppl 4():S298-303. PubMed ID: 2047653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity.
    Ling H; Pannu NS; Boodhoo A; Armstrong GD; Clark CG; Brunton JL; Read RJ
    Structure; 2000 Mar; 8(3):253-64. PubMed ID: 10745005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.
    Louise CB; Obrig TG
    J Infect Dis; 1995 Nov; 172(5):1397-401. PubMed ID: 7594687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
    Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
    Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.
    Lindgren SW; Samuel JE; Schmitt CK; O'Brien AD
    Infect Immun; 1994 Feb; 62(2):623-31. PubMed ID: 8300218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verotoxin receptor glycolipid in human renal tissue.
    Boyd B; Lingwood C
    Nephron; 1989; 51(2):207-10. PubMed ID: 2644572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.
    Waddell T; Cohen A; Lingwood CA
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7898-901. PubMed ID: 2236008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
    Cooling LL; Walker KE; Gille T; Koerner TA
    Infect Immun; 1998 Sep; 66(9):4355-66. PubMed ID: 9712788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
    Perera LP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-independent retrograde targeting of glycolipids to the Golgi complex.
    Schapiro FB; Lingwood C; Furuya W; Grinstein S
    Am J Physiol; 1998 Feb; 274(2):C319-32. PubMed ID: 9486120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verotoxin-resistant cell clones are deficient in the glycolipid globotriosylceramide: differential basis of phenotype.
    Pudymaitis A; Armstrong G; Lingwood CA
    Arch Biochem Biophys; 1991 May; 286(2):448-52. PubMed ID: 1910293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences.
    Armstrong GD; Fodor E; Vanmaele R
    J Infect Dis; 1991 Dec; 164(6):1160-7. PubMed ID: 1659599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells.
    Jacewicz MS; Acheson DW; Mobassaleh M; Donohue-Rolfe A; Balasubramanian KA; Keusch GT
    J Clin Invest; 1995 Sep; 96(3):1328-35. PubMed ID: 7657808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity.
    Weinstein DL; Jackson MP; Perera LP; Holmes RK; O'Brien AD
    Infect Immun; 1989 Dec; 57(12):3743-50. PubMed ID: 2807546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.
    Lingwood CA; Law H; Richardson S; Petric M; Brunton JL; De Grandis S; Karmali M
    J Biol Chem; 1987 Jun; 262(18):8834-9. PubMed ID: 3298243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shiga-like toxin purges human lymphoma from bone marrow of severe combined immunodeficient mice.
    LaCasse EC; Saleh MT; Patterson B; Minden MD; Gariépy J
    Blood; 1996 Sep; 88(5):1561-7. PubMed ID: 8781410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis.
    O'Brien AD; Tesh VL; Donohue-Rolfe A; Jackson MP; Olsnes S; Sandvig K; Lindberg AA; Keusch GT
    Curr Top Microbiol Immunol; 1992; 180():65-94. PubMed ID: 1324134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.